Search results
The 5 Stocks Defining 'The Year Of The Dividend' In 2024
Benzinga via Yahoo Finance· 2 days agoReinvested stock dividends have significantly influenced the total return of the S&P 500 since 1927....
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Zacks via Yahoo Finance· 6 days agoBristol Myers' (BMY) Opdivo combination regimen receives the European Commission's approval for the...
2024 is being called ‘the year of the dividend.’ These 5 stocks keep on giving.
MarketWatch via Yahoo Finance· 4 days agoGetty Images/iStockphoto - Stock dividends are anything but boring — they’re responsible for 36% of...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 5 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 4 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 6 days ago, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for an...
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Zacks· 7 days agoFree Report) announced that the European Commission (EC) has approved its blockbuster immuno-oncology drug, Opdivo (nivolumab), in combination with a chemotherapy combination, cisplatin and ...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 2 days agoTwo trials show positive outcomes
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace via Yahoo Finance· 6 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace· 6 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...